This Virtual Program was held on March 25, 2021.
During this interactive online program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.
Clifford Goodman, PhD
Senior Vice President
The Lewin Group
|12:00 – 12:05 PM|
Beth Gaffney, MBA
|12:05 – 1:30 PM|
Module I: Meet the Guidelines Panel Experts
Professor of Gynecology and Obstetrics
Professor of Medicine,
|1:30 – 1:45 PM|
|1:45 – 2:55 PM|
Module II: Future of the Affordable Care Act
Cancer Care Innovation
|2:55 – 3:00 PM|
Gary J. Weyhmuller, MBA, SPHR
*Curriculum subject to change. All times are EDT, see World Clock here.
Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.
Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.
NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.